Announced
Completed
Synopsis
Armira, a holding group focused on direct investments in privately-held medium-sized "Mittelstand" businesses, completed the acquisition of a 40% stake in Sartorius, an international pharmaceutical and laboratory equipment supplier, for €2.5bn. In total, the inheritances of the community of heirs comprise 50.09% of the ordinary shares of Dax listed Sartorius Aktiengesellschaft. Unaffected by the transaction, all shares held by the community of heirs continue to be subject to the execution of the will by an executor until mid-2028. In a separate, parallel transaction, Karin Sartorius-Herbst, the eldest daughter of testator Horst Sartorius, increased her existing stake within the community of heirs.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.